Gritstone Oncology Announces $110 Million Private Placement

NEXT STORY
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Plans on Emergency Use Access
PREV STORY
Correction: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

iCRYO Announces the Formation of Their Medical Advisory Board

author_avatar
NASDAQ Market News

ASLAN Pharmaceuticals Announces Closing of US$15 Million Public Offering of American Depositary Shares, Including Full Exercise of Underwriter’s Option to Purchase Additional ADSs

author_avatar
NASDAQ Market News

Dry Mouth Relief Market Valuation to Surpass USD 2,777.14 Million by 2026, at 4.10% CAGR, Asserts Market Research Future (MRFR)

author_avatar
NASDAQ Market News